Search research articles
Contact Us
Filters
Showing results (81-90 of 169) with videos related to
Page
of 17
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 31, 2012
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
Michael C Haffner, Johannes Laimer, Alcides Chaux, et al.
Cancer Research
|
November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity
Srinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.
Neoplasia (New York, N.Y.)
|
March 15, 2025
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer
Anbarasu Kumaraswamy, Rahul Mannan, Olivia A Swaim, et al.
Communications Biology
|
September 1, 2022
Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
Tamara S Rodems, Erika Heninger, Charlotte N Stahlfeld, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2024
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received <sup>177</sup>Lu-PSMA-617: Importance of <sup>18</sup>F-FDG-Avid Discordant Findings
Ridvan Arda Demirci, Alireza Ghodsi, Roman Gulati, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas
Antoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
May 30, 2020
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
David Esopi, Mindy Kim Graham, Jacqueline A Brosnan-Cashman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies
Michael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Nature Communications
|
February 20, 2026
Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity
Richa Singh, Varadha Balaji Venkadakrishnan, Eddie Imada, et al.
Science Translational Medicine
|
January 25, 2013
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases
Martin J Aryee, Wennuan Liu, Julia C Engelmann, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 169) with videos related to
Sort By:
Page
of 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 31, 2012
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
Michael C Haffner, Johannes Laimer, Alcides Chaux, et al.
Cancer Research
|
November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity
Srinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.
Neoplasia (New York, N.Y.)
|
March 15, 2025
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer
Anbarasu Kumaraswamy, Rahul Mannan, Olivia A Swaim, et al.
Communications Biology
|
September 1, 2022
Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
Tamara S Rodems, Erika Heninger, Charlotte N Stahlfeld, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2024
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received <sup>177</sup>Lu-PSMA-617: Importance of <sup>18</sup>F-FDG-Avid Discordant Findings
Ridvan Arda Demirci, Alireza Ghodsi, Roman Gulati, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas
Antoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
May 30, 2020
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
David Esopi, Mindy Kim Graham, Jacqueline A Brosnan-Cashman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies
Michael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Nature Communications
|
February 20, 2026
Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity
Richa Singh, Varadha Balaji Venkadakrishnan, Eddie Imada, et al.
Science Translational Medicine
|
January 25, 2013
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases
Martin J Aryee, Wennuan Liu, Julia C Engelmann, et al.
Page
of 17